Tu canal independiente de oncología en español
Top resúmenes y presentaciones
ESMO 2024
GINECOLÓGICO
Regístrate aquí para recibir más contenidos
Registrarse
ENDOMETRIAL
Immunotherapy plus Chemotherapy in the First-line
Treatment for Primary Advanced or Recurrent Endometrial
Cancer: An Extracted Individual Patient Data and Trial-Level
Meta-Analysis
743P
Safety and efficacy of sacituzumab tirumotecan (sac-TMT)
in patients (pts) with previously treated advanced
endometrial carcinoma (EC) and ovarian cancer (OC) from
a phase II study
715MO
ENGOT-en11/GOG-3053/KEYNOTE-B21: A phase III study of
pembrolizumab or placebo in combination with adjuvant
chemotherapy with or without radiotherapy in patients
with newly diagnosed, high-risk endometrial cancer.
LBA28
Comparison of the Idylla™ Microsatellite Instability (MSI)
test with a gold standard MSI test and mismatch repair
immunohistochemistry in endometrial cancer
741P